Site icon pharmaceutical daily

1-Day Seminar: Drafting & Negotiating Clinical Trial Agreements

blood sample and a pipette in the lab. Illustration

DUBLIN–(BUSINESS WIRE)–The “Drafting
and Negotiating Clinical Trial Agreements”
conference has been
added to ResearchAndMarkets.com’s offering.

Clinical trial agreements are one of the most important agreements in
the pharma industry as no research can start without the right agreement
in place between sponsor and host organisation. They provide a contract
which manages the relationship and responsibilities of both parties, and
provide for the allocation of risk, obligations, the protection of
academia, terms of collaboration, IP rights and much more.

This intensive one-day programme, delivered by experts
in the field, will provide you with a full understanding of the
importance of CTAs. It will describe how the regulatory environment
affects them and explain the typical clauses which make up a CTA and
what the key differences are between European and the US. By the end of
this seminar you will be confident in spotting and addressing issues
which arise when negotiating and drafting clinical trial agreements.

Who Should Attend?

Agenda

Overview of the legal/policy landscape as it affects the terms of CTAs:

CASE STUDY

Negotiating and drafting CTAs:

CASE STUDY

Negotiating and drafting CTAs – Continued discussion of case study:

Additional considerations:

PRACTICAL EXERCISE – Negotiation

For more information about this conference visit https://www.researchandmarkets.com/r/6lx8xl

Image: Illustration

Exit mobile version